This campaign has now closed
The Cure Parkinson’s Trust is launching a special appeal to fund a project that could have life-changing implications for those living with Parkinson’s. The budget shown here is currently being revised and will be in the region of 1.3 million of which we are pledged to fund £650,000.
Categories
Beneficiaries
Situation
Glial Derived Neurotrophic Factor (GDNF) showed remarkable neurorestorative and neuroprotective effects in early trials on people with Parkinson’s. Since then, the work on GDNF has been held back following commercial delays, but none of these have diminished the extraordinary potential of this therapy.
Solution
Professor Gill pioneered the original work using GDNF. Since the initial pilot study, CPT has supported Professor Gill in the design of a system to enable this key growth factor to be delivered optimally. Starting in 2011, Professor Gill plans to conduct